Postpartum hormones oxytocin and prolactin cause pro-arrhythmic prolongation of cardiac repolarization in long QT syndrome type 2.


Journal

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology
ISSN: 1532-2092
Titre abrégé: Europace
Pays: England
ID NLM: 100883649

Informations de publication

Date de publication:
01 Jul 2019
Historique:
received: 13 11 2018
accepted: 21 02 2019
pubmed: 3 4 2019
medline: 3 11 2020
entrez: 3 4 2019
Statut: ppublish

Résumé

Women with long QT syndrome 2 (LQT2) have a particularly high postpartal risk for lethal arrhythmias. We aimed at investigating whether oxytocin and prolactin contribute to this risk by affecting repolarization. In female transgenic LQT2 rabbits (HERG-G628S, loss of IKr), hormone effects on QT/action potential duration (APD) were assessed (0.2-200 ng/L). Hormone effects (200 ng/L) on ion currents and cellular APD were determined in transfected cells and LQT2 cardiomyocytes. Hormone effects on ion channels were assessed with qPCR and western blot. Experimental data were incorporated into in silico models to determine the pro-arrhythmic potential. Oxytocin prolonged QTc and steepened QT/RR-slope in vivo and prolonged ex vivo APD75 in LQT2 hearts. Prolactin prolonged APD75 at high concentrations. As underlying mechanisms, we identified an oxytocin- and prolactin-induced acute reduction of IKs-tail and IKs-steady (-25.5%, oxytocin; -13.3%, prolactin, P < 0.05) in CHO-cells and LQT2-cardiomyocytes. IKr currents were not altered. This oxytocin-/prolactin-induced IKs reduction caused APD90 prolongation (+11.9%/+13%, P < 0.05) in the context of reduced/absent IKr in LQT2 cardiomyocytes. Hormones had no effect on IK1 and ICa,L in cardiomyocytes. Protein and mRNA levels of CACNA1C/Cav1.2 and RyR2 were enhanced by oxytocin and prolactin. Incorporating these hormone effects into computational models resulted in reduced repolarization reserve and increased propensity to pro-arrhythmic permanent depolarization, lack of capture and early afterdepolarizations formation. Postpartum hormones oxytocin and prolactin prolong QT/APD in LQT2 by reducing IKs and by increasing Cav1.2 and RyR2 expression/transcription, thereby contributing to the increased postpartal arrhythmic risk in LQT2.

Identifiants

pubmed: 30938413
pii: 5425252
doi: 10.1093/europace/euz037
doi:

Substances chimiques

Oxytocin 50-56-6
Prolactin 9002-62-4

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1126-1138

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Informations de copyright

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2019. For permissions, please email: journals.permissions@oup.com.

Auteurs

Ilona Bodi (I)

Department of Cardiology and Angiology I, Heart Center University of Freiburg, Hugstetter Str. 55, Freiburg, Germany.
Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Institute for Experimental Cardiovascular Medicine, University Heart Center Freiburg - Bad Krozingen and Medical Center - University of Freiburg, Freiburg, Germany.

Jonathan Sorge (J)

Department of Cardiology and Angiology I, Heart Center University of Freiburg, Hugstetter Str. 55, Freiburg, Germany.
Faculty of Medicine, University of Freiburg, Freiburg, Germany.

Alessandro Castiglione (A)

Department of Cardiology and Angiology I, Heart Center University of Freiburg, Hugstetter Str. 55, Freiburg, Germany.
Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Institute for Experimental Cardiovascular Medicine, University Heart Center Freiburg - Bad Krozingen and Medical Center - University of Freiburg, Freiburg, Germany.

Sylva M Glatz (SM)

Department of Cardiology and Angiology I, Heart Center University of Freiburg, Hugstetter Str. 55, Freiburg, Germany.
Faculty of Medicine, University of Freiburg, Freiburg, Germany.

Eike M Wuelfers (EM)

Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Institute for Experimental Cardiovascular Medicine, University Heart Center Freiburg - Bad Krozingen and Medical Center - University of Freiburg, Freiburg, Germany.

Gerlind Franke (G)

Department of Cardiology and Angiology I, Heart Center University of Freiburg, Hugstetter Str. 55, Freiburg, Germany.
Faculty of Medicine, University of Freiburg, Freiburg, Germany.

Stefanie Perez-Feliz (S)

Department of Cardiology and Angiology I, Heart Center University of Freiburg, Hugstetter Str. 55, Freiburg, Germany.
Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Institute for Experimental Cardiovascular Medicine, University Heart Center Freiburg - Bad Krozingen and Medical Center - University of Freiburg, Freiburg, Germany.

Gideon Koren (G)

Division of Cardiology, Cardiovascular Research Center, Rhode Island Hospital, Alpert Medical School of Brown University, Providence, RI, USA.

Manfred Zehender (M)

Department of Cardiology and Angiology I, Heart Center University of Freiburg, Hugstetter Str. 55, Freiburg, Germany.
Faculty of Medicine, University of Freiburg, Freiburg, Germany.

Heiko Bugger (H)

Department of Cardiology and Angiology I, Heart Center University of Freiburg, Hugstetter Str. 55, Freiburg, Germany.
Faculty of Medicine, University of Freiburg, Freiburg, Germany.

Gunnar Seemann (G)

Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Institute for Experimental Cardiovascular Medicine, University Heart Center Freiburg - Bad Krozingen and Medical Center - University of Freiburg, Freiburg, Germany.

Michael Brunner (M)

Department of Cardiology and Angiology I, Heart Center University of Freiburg, Hugstetter Str. 55, Freiburg, Germany.
Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Department of Cardiology and Medical Intensive Care, St. Josefskrankenhaus, Freiburg, Germany.

Christoph Bode (C)

Department of Cardiology and Angiology I, Heart Center University of Freiburg, Hugstetter Str. 55, Freiburg, Germany.
Faculty of Medicine, University of Freiburg, Freiburg, Germany.

Katja E Odening (KE)

Department of Cardiology and Angiology I, Heart Center University of Freiburg, Hugstetter Str. 55, Freiburg, Germany.
Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Institute for Experimental Cardiovascular Medicine, University Heart Center Freiburg - Bad Krozingen and Medical Center - University of Freiburg, Freiburg, Germany.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH